Anteris Technologies enters $250M ATM equity offering with TD Cowen to fund DurAVR heart valve development

Anteris Technologies Global Corp.

Entered into Sales Agreement with TD Securities (USA) LLC for at-the-market offering of up to $250M of common stock.
Commission payable to TD Cowen is 3.0% of gross proceeds for sales as agent.
Net proceeds primarily for ongoing development of DurAVR Transcatheter Heart Valve System and working capital.
Sales may be made on Nasdaq, in negotiated transactions, or block trades; company controls timing and size.
Offering terminates upon sale of all shares or either party giving 10 days' notice; shelf effective since Jan 8, 2026.

item 1.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001140361-26-022633
form_type: 8-K
ticker: AVR
cik: 0002011514
company_name: Anteris Technologies Global Corp.
filed_at: 2026-05-22T21:15:41+00:00
discovered_at: 2026-05-22T21:18:00.274625+00:00
generated_at: 2026-05-22T21:23:01.054931+00:00
sec_items: ["1.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001140361-26-022633
json_url: https://secwatch.observer/filing/0001140361-26-022633.json
markdown_url: https://secwatch.observer/filing/0001140361-26-022633.md
text_url: https://secwatch.observer/filing/0001140361-26-022633.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2011514/000114036126022633/0001140361-26-022633-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2011514/000114036126022633/ny20074564x2_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001140361-26-022633

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.